Effect of Hydrocortison on Post-ischemic Flow-mediated Dilation and on Thenar Oxygen Saturation in Human Septic Shock. (HyStOON)
Effect of Intravenous Hydrocortison on Post-ischemic Brachial Artery Dilation and on Thenar Oxygen Saturation in Adult Septic Shock. A Human Placebo-controlled Randomized Study.
Sponsor: Centre Hospitalier Régional d'Orléans
Terminated
not enough recruitment
Other terminated trials from Centre Hospitalier Régional d'Orléans
- Stroke, Acute · Phase NA · Aug 2024
- Hypovolemia · Phase NA · May 2024
- COVID-19 · Phase NA · Mar 2023
- Parkinson Disease · Phase NA · Dec 2022
- Muscle Weakness · Phase NA · Dec 2021
See all terminations from Centre Hospitalier Régional d'Orléans
Other Adult trials with similar outcome
Listed as NCT01817153, this PHASE2/PHASE3 trial focuses on Adult and Septic Shock and remains terminated or withdrawn. Sponsored by Centre Hospitalier Régional d'Orléans, it has been updated 7 times since 2013, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE2/PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE2/PHASE3
Phase: PHASE2_PHASE3 → PHASE2/PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Terminated PHASE2_PHASE3
-
Mar 2020 — Jan 2021 [monthly]
Terminated PHASE2_PHASE3
Status: Unknown Status → Terminated
-
Jan 2020 — Mar 2020 [monthly]
Unknown Status PHASE2_PHASE3
Status: Recruiting → Unknown Status
▶ Show 2 earlier versions
-
Jun 2018 — Jan 2020 [monthly]
Recruiting PHASE2_PHASE3
-
Jan 2017 — Jun 2018 [monthly]
Recruiting PHASE2_PHASE3
First recorded
Nov 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Centre Hospitalier Régional d'Orléans
For direct contact, visit the study record on ClinicalTrials.gov .